Buchumschlag

The association between proton‐pump inhibitor use and recurrence of hepatocellular carcinoma after hepatectomy

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Chun‐Ting Ho, Chia‐Chu Fu, Elise Chia‐Hui Tan, Wei‐Yu Kao, Pei‐Chang Lee, Yi‐Hsiang Huang, Teh‐Ia Huo, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Journal of Gastroenterology and Hepatology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Risk Prediction Model for HCC in Subjects Without Apparent Chronic Liver Disease: A Dilemma in Asia
von: Teh‐Ia Huo, et al.
Veröffentlicht: (2025)

MRI for hepatocellular carcinoma and the role of abbreviated MRI for surveillance of hepatocellular carcinoma
von: Soe Thiha Maung, et al.
Veröffentlicht: (2024)

Allergic phenotype identified on allergen testing is associated with proton pump inhibitor nonresponse in eosinophilic esophagitis
von: Mayssan Muftah, et al.
Veröffentlicht: (2024)

Comparison of six hepatocellular carcinoma prediction models in Japanese patients after sustained virologic response undergoing rigorous surveillance for hepatocellular carcinoma
von: Hidenori Toyoda, et al.
Veröffentlicht: (2024)

Role of hepatitis B core‐related antigen in predicting the occurrence and recurrence of hepatocellular carcinoma in patients with chronic hepatitis B: A systemic review and meta‐analysis
von: Qi‐Hang Cao, et al.
Veröffentlicht: (2024)

Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma
von: Seung Kak Shin, et al.
Veröffentlicht: (2024)

Exosomal mRNA in plasma serves as a predictive marker for microvascular invasion in hepatocellular carcinoma
von: Zhaodan Xin, et al.
Veröffentlicht: (2024)

Recurrence risk prediction models for hepatocellular carcinoma after liver transplantation
von: Xu Zhang, et al.
Veröffentlicht: (2024)

Artificial intelligence in hepatocellular carcinoma diagnosis: a comprehensive review of current literature
von: Odysseas P. Chatzipanagiotou, et al.
Veröffentlicht: (2024)

Cilostazol improves the prognosis after hepatectomy in rats with sinusoidal obstruction syndrome
von: Hiroaki Sugita, et al.
Veröffentlicht: (2024)

Hepatitis B surface antigen loss in chronic hepatitis B patients with low‐viral‐load
von: Tyng‐Yuan Jang, et al.
Veröffentlicht: (2024)

Impact of immune‐related adverse events in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab
von: Keito Suzuki, et al.
Veröffentlicht: (2024)

Metabolic‐associated fatty liver disease and hepatocellular carcinoma: a prospective study of characteristics and response to therapy
von: NM Batt, et al.
Veröffentlicht: (2024)

Lower hepatocellular carcinoma surveillance in metabolic dysfunction‐associated steatotic liver disease: Impact on treatment eligibility
von: Connor Henry‐Blake, et al.
Veröffentlicht: (2024)

Cumulative Dose of Regorafenib in Patients With Metastatic Colorectal Cancer: A Multicenter Cohort Study
von: Yu‐Hsuan Kuo, et al.
Veröffentlicht: (2025)

Proton pump inhibitors associated with severe COVID‐19 among two‐dose but not three‐dose vaccine recipients
von: Ka Shing Cheung, et al.
Veröffentlicht: (2024)

Developing a feasible classification model for surgical hepatocellular carcinoma: More questions than answers
von: Teh‐Ia Huo, et al.
Veröffentlicht: (2024)

Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
von: Yi‐Ting Chen, et al.
Veröffentlicht: (2024)

Clinical outcomes of transarterial chemoembolization in Child–Turcotte Pugh class A patients with a single small (≤3 cm) hepatocellular carcinoma
von: Jungnam Lee, et al.
Veröffentlicht: (2024)

Changes in clinical outcomes in Japanese patients with hepatocellular carcinoma due to hepatitis C virus following the development of direct‐acting antiviral agents
von: Hideko Ohama, et al.
Veröffentlicht: (2024)

Steatotic Liver Disease‐Related Polygenetic Risk Score Prediction of Hepatocellular Carcinoma in Nucleotide/Nucleoside Analog‐Treated Chronic Hepatitis B
von: Tyng‐Yuan Jang, et al.
Veröffentlicht: (2025)

Sequential Treatment of Metastatic Colorectal Cancer in Taiwan: Real‐World Evidence From Regorafenib and Trifluridine/Tipiracil Use
von: Ya‐Wen Chang, et al.
Veröffentlicht: (2025)

Hepatic arterial infusion therapy for advanced hepatocellular carcinoma after systemic treatment failure: A treatment dilemma
von: Teh‐Ia Huo, et al.
Veröffentlicht: (2024)

Clinical Trial: The Optimal Timing of the Endoscope Insertion After Oral Lidocaine Spray. A Randomized Controlled Trial
von: Hsueh‐Chien Chiang, et al.
Veröffentlicht: (2025)

Short and Endurance Squeeze Contractile Integral in High‐Resolution Anorectal Manometry Is Correlated With Vaizey Incontinence Score—A Pilot Study
von: Jia‐Feng Wu, et al.
Veröffentlicht: (2025)

Incidences of Virological and Clinical Relapses After Cessation of Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Entecavir in Patients With HBeAg‐Negative Chronic Hepatitis B
von: Cheng‐Hao Tseng, et al.
Veröffentlicht: (2025)

Distinct characteristics of various autoimmune liver diseases: A 22‐year hospital‐based study in Taiwan
von: Ming‐Ling Chang, et al.
Veröffentlicht: (2024)

Multicenter evaluation of the safety and efficacy of selective internal radiation therapy with yttrium‐90 resin microspheres in Taiwan: data from the RESIN registry
von: Rheun‐Chuan Lee, et al.
Veröffentlicht: (2024)

Mediterranean Diet Adherence Is Associated With Reduced Liver Fibrosis Risk in Metabolic Dysfunction–Associated Steatotic Liver Disease
von: Meng‐Lun Hsieh, et al.
Veröffentlicht: (2026)

IgG4‐Associated Autoimmune Hepatitis: a Systematic Review
von: Chun‐Hsun Liao, et al.
Veröffentlicht: (2026)

Hepatic arterial infusion chemotherapy combined with lenvatinib and PD‐1 inhibitors versus lenvatinib and PD‐1 inhibitors for HCC refractory to TACE
von: Lingfeng Diao, et al.
Veröffentlicht: (2024)

The impact of sodium‐glucose cotransporter‐2 inhibitors on outcome of patients with diabetes mellitus and colorectal cancer
von: Cho‐Han Chiang, et al.
Veröffentlicht: (2024)

Esophageal cancer mortality disparities between Black and White adults in the United States, 1999–2020: insights from CDC‐WONDER
von: Chun‐Wei Pan, et al.
Veröffentlicht: (2024)

Rifaximin treatment shapes a unique metagenome‐metabolism network in patients with decompensated cirrhosis
von: Mei‐Tong Nie, et al.
Veröffentlicht: (2024)

Gastrointestinal: An unusual large pancreatic head tumor: Pancreatic acinar cell carcinoma
von: H‐C Oh, et al.
Veröffentlicht: (2024)

Prevalence and disease burden of gastroparesis in Asia
von: Ching‐Tung Hsu, et al.
Veröffentlicht: (2024)

Gastrointestinal: An Unexpected Scene of Epigastric Pain in Chronic Pancreatitis
von: Meng‐Hsuan Lu, et al.
Veröffentlicht: (2025)

Gastrointestinal: Colorectal metastases from gastric poorly differentiated carcinoma presenting as a diminutive polyp
von: K Shiotsuki, et al.
Veröffentlicht: (2024)

Two‐stage deep‐learning‐based colonoscopy polyp detection incorporating fisheye and reflection correction
von: Chen‐Ming Hsu, et al.
Veröffentlicht: (2024)

Relationship between Helicobacter pylori infection, osteoporosis, and fracture
von: Jing Tong Tan, et al.
Veröffentlicht: (2024)